Profile
VeriLuce Therapeutics is a research and discovery/early-stage drug development Company focusing on designing and developing novel small molecules antagonizing two receptors within the immune-tumor micro-environment in dualistic mode in order to slow down/stop cancer growth; the two receptor targets belong to the GPCR chemokine receptor family. By targeting the two specific chemokine receptors, we believe that the tumor micro-environment will be modified so as to favour increased tumor cells killing and metastasis. Targeting chemokine receptors in dual antagonistic fashion is more potent, more efficacious and less prone to side effects creation than targeting receptors in single antagonistic mode.
Website
www.verilucetherapeutics.comContact
-
Elena Frigerio, Founder and Chief Executive OfficerTel: +1 647 965-1963
Event details
Date: June 13 - 16, 2022
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
26 in total
-
A4i is a patent pending, validated, digital therapeutic with a regulatory pathway for severe mental illness. A4i's… -
AmacaThera Inc., a clinical-stage company transforming therapeutics to make a difference in patient health. AmacaGel… -
Arbor Life Labs has technology that regulates the Wnt/?-Catenin pathway complemented by modulating disease and tissue… -
Bay Area Health Trust (BAHT) operates and invests in healthcare and life science related companies.… -
Custom Biologics is Canada’s leading regulatory-compliant large molecule CRO. For more than 18 years,… -
Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of… -
Dalton Pharma Services is a leading North American cGMP pharmaceutical organization providing integrated drug discovery… -
Environmental Systems Corporation (ESC) designs, manufactures, constructs and validates cleanrooms,… -
Mannin Research Inc. is a Canadian biotechnology company with a subsidiary in Germany, Mannin GmbH. Our… -
Mediphage, a preclinical-stage biotechnology company, is developing a next-generation gene therapy platform based on… -
Nanology Labs is a Canadian biotechnology company focused on advancing the development of T-MX, a first-in-class… -
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP… -
Orange Neurosciences is a rapidly growing multi-product global digital health startup in psychiatry and neurology.… -
Ovensa Inc. works with pharmaceutical companies to enhance the stability and delivery of their RNA… -
panCELLa is a Toronto based biotech company with a focus on gene editing and cellular therapies. panCELLa seeks to… -
Pattern is a North American immunotherapy company whose systemically-administered TLR4 agonist activates the innate… -
PlantForm develops and manufactures proteins and antibodies using our plant based vivoXPRESS® expression system.… -
Polyanalytik is a contract research laboratory that specializes in the analysis of polymers and biopolymers used… -
ProteinQure is a computational platform for protein drug discovery. We partner with pharma to deliver experimentally… -
PurMinds is an innovative precision NeuroMedicine company pursuing breakthrough solutions to neurodegenerative diseases… -
Spiderwort is a biomaterials company developing cellulose-based scaffolds for use in regenerative medicine. Its lead… -
SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision… -
Stiris is a Clinical Trial Management company conducting Phase I-IIIB trials for biotech and biopharma. Located in… -
VeriLuce Therapeutics is a research and discovery/early-stage drug development Company focusing on designing and…
-
Traditional neurological assessments are slow, subjective, and difficult to do remotely. Winterlight’s technology can…